# A Study of JNJ-70075200 in Healthy Participants

> **NCT04782661** · PHASE1 · WITHDRAWN · sponsor: **Janssen Research & Development, LLC**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-70075200
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04782661
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-01
- **Primary completion:** 2022-05-09
- **Final completion:** 2022-09-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Program terminated prior to enrolling subjects
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04782661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04782661, "A Study of JNJ-70075200 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04782661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*